Featured Issue Briefs
The Battle on the Home Front: Jonathan Gadsden's Story
Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More
Facilitating Medical Device Innovation: De Novo Reform
The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More
Food Products Recalled by FDA
Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More
More Issue Briefs
| Date | Issue Briefs | Topic |
|---|---|---|
| Jul 24, 2009 |
Letter to the Assistant to the President for Domestic PolicyOur combined memberships include the country’s foremost scientific and medical experts and represent more than eleven million concerned Americans and health professionals. Our position is based on objective health interests and concerns that dangerous drug resistant infections are rapidly increasing in hospitals and community settings adding to the economic burden of the U.S. healthcare costs. More info |
Antibiotics in Food Animal Production |
| Jul 21, 2009 |
Pew letter to the FDA in response to their public recognition of animal agriculture's contribution to antimicrobial resistanceThe Pew Campaign on Human Health and Industrial Farming (Pew) would like to extend our sincere thanks to you both for taking the time to meet with us on June 23 to discuss the contribution of animal agriculture to the growing public health crisis of antimicrobial resistance. We are deeply appreciative not only of your consideration of our viewpoints, but also the expertise and dedication that you bring to the U.S. Food and Drug Administration (FDA). More info |
Antibiotics in Food Animal Production |
| Jul 15, 2009 |
Testimony: Robert P. Martin Before the U.S. House of Representatives Committee on RulesTestimony from Robert P. Martin, Senior Officer, Pew Environment Group, before the U.S. House of Representatives Committee on Rules regarding the Preservation of Antibiotics for Medical Treatment Act (PAMTA). More info |
Antibiotics in Food Animal Production |
| Apr 30, 2009 |
No Economic Advantage to Industrialized Pork ProductionIn October 2008, a panel formed to conduct a comprehensive, fact-based examination of key aspects of the farm animal industry. The report found that the current industrial method of raising pigs for food carries no economic advantage over more natural pig farming. The researchers determined that when the costs to society and communities are taken into account – particularly the costs of waste treatment - industrial animal production actually carries a higher price tag. More info |
Antibiotics in Food Animal Production |
| Mar 17, 2009 |
Teleconference on Legislation to Help Curtail Overuse of Antibiotics on Factory FarmsChipotle restaurant CEO joins Rep. Louise Slaughter (D-NY) and leading antibiotic expert to discuss the Preservation of Antibiotics for Medical Treatment Act of 2009. More info |
Antibiotics in Food Animal Production |
| Jun 26, 2013 |
Drug Development for Limited Populations: A New Proposed PathwayThe lack of new antibiotics and the rise in drug resistance have rendered some serious and life-threatening infections untreatable, and the health care community is searching for ways to bring innovative new drugs to patients whose treatment options are limited or nonexistent. More info |
Antibiotic Innovation |
| Aug 16, 2012 |
The Battle on the Home Front: The Jonathan Gadsden StorySince Operations Iraqi Freedom and Enduring Freedom began, many American servicemen and women have been infected with antibiotic-resistant bacteria. While our men and women in uniform increasingly survive severe wounds sustained in combat, their injuries leave them susceptible to life-threatening, hard-to-treat infections. Marine Lance Corporal Jonathan Gadsden’s story reflects the growing need for new antibiotics that can treat these dangerous diseases, against which most drugs are useless. More info |
Antibiotic Innovation |
| May 31, 2012 |
Unmet Medical Need in Infectious DiseasesIntroduced more than 75 years ago, antibiotics have profoundly transformed health care. Thanks to these drugs and to advances in vaccines and infection control, many formerly devastating bacterial illnesses can be cured or contained. More info |
Antibiotic Innovation |
| Mar 1, 2012 |
MRSA on the Appalachian Trail: The Story of Steve WeiselHiking the Appalachian Trail, Steve Weisel thought little of the blisters on his feet until he discovered they were infected with life-threatening methicillin-resistant Staphylococcus aureus (MRSA) -- an increasingly common "superbug" that does not respond to first-line antibiotics. Mr. Weisel's story demonstrates the urgent need for new and innovative therapies to treat this growing threat. More info |
Antibiotic Innovation |
| Mar 1, 2012 |
The Threat of Multidrug-Resistant Infections to ChildrenExpert testimony, research, and commentary More info |
Antibiotic Innovation |
